Marc Voigt

Marc Voigt currently works at Immutep Ltd., as Chief Executive Officer & Executive Director, Immutep SAS, as Chairman-Supervisory Board & President from 2015, Immutep GmbH, as Co-Managing Director, and Pharma-Lizenz-Club Deutschland, as Member.
Mr. Voigt also formerly worked at Elanix Biotechnologies AG, as Vice Chairman-Supervisory Board, Medical Enzymes AG, as Director-Finance, Legal & Business Development from 2001 to 2006, Allianz SE, as Principal from 2001 to 2009, Revotar Biopharmaceuticals AG, as Chief Financial Officer from 2003 to 2006, Allianz Versicherungs AG, as Principal, caprotec bioanalytics GmbH, as MD, Chief Operating & Financial Officer, and Immutep GmbH, as General Manager-European Operations.
Mr. Voigt received his Masters Business Admin degree from Freie Universität Berlin.